Elsevier

Neuroscience Letters

Volume 431, Issue 1, 24 January 2008, Pages 1-5
Neuroscience Letters

Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex

https://doi.org/10.1016/j.neulet.2007.11.009Get rights and content

Abstract

Δ9-Tetrahydrocannabinol, the main psychoactive ingredient in marijuana, activates specific cannabinoid (CB) receptors to exert complex actions on modulatory neurotransmitters involved in attention and cognition. Previous research has demonstrated that systemic administration of the synthetic cannabinoid agonist, WIN 55,212-2, increases norepinephrine efflux in the frontal cortex. The distribution of CB1 receptors on noradrenergic fibers in the frontal cortex suggests this may be one potential site for the regulation of norepinephrine release. In the present study, we first examined the ability of a CB1 antagonist, applied locally in the frontal cortex of adult male Sprague–Dawley rats, to block the actions of systemic WIN 55,212-2. Pretreatment with SR 141716A (300 μM) significantly attenuated the excitatory effects of WIN 55,212-2 (15 mg/kg, i.p.). Next, the impact of direct perfusion of WIN 55,212-2 into the frontal cortex on extracellular norepinephrine efflux was measured. Direct application of WIN 55,212-2 (100 μM) into the frontal cortex elicited a significant increase in extracellular norepinephrine efflux suggesting that activation of cortical cannabinoid receptors contributes to alterations in norepinephrine levels in this brain region. Finally, local administration of SR 141716A followed by local administration of WIN 55,212-2 revealed a paradoxical inhibition of norepinephrine efflux.

Section snippets

Acknowledgements

The authors acknowledge the technical assistance of Ms. Y. Qian and Ms. M.L. Livingstone Supported by NIDA DA 020129, DA 15395 and V.O. was supported by a Minority Student Supplement to DA 09082 from NIDA.

References (46)

  • V. Santucci et al.

    Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep–waking cycle analysis

    Life Sci.

    (1996)
  • E. Schlicker et al.

    Modulation of transmitter release via presynaptic cannabinoid receptors

    Trends Pharmacol. Sci.

    (2001)
  • N. Solowij et al.

    Differential impairments of selective attention due to frequency and duration of cannabis use

    Biol. Psychiatry

    (1995)
  • E.T. Tzavara et al.

    The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

    Eur. J. Pharmacol.

    (2001)
  • E.S. Vizi et al.

    Evidence for presynaptic cannabinoid CB(1) receptor-mediated inhibition of noradrenaline release in the guinea pig lung

    Eur. J. Pharmacol.

    (2001)
  • M.R. Wade et al.

    Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study

    Brain Res.

    (2004)
  • B.D. Waterhouse et al.

    New evidence for a gating action of norepinephrine in central neuronal circuits of mammalian brain

    Brain Res. Bull.

    (1988)
  • A.F. Arnsten

    Catecholamine regulation of the prefrontal cortex

    J. Psychopharmacol.

    (1997)
  • G. Aston-Jones

    Behavioral functions of locus coeruleus derived from cellular attributes

    Physiol. Psychol.

    (1985)
  • G. Aston-Jones et al.

    Anatomy and physiology of locus coeruleus neurons: functional implications

  • F. Berrendero et al.

    Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol

    Psychopharmacology (Berl)

    (2002)
  • S. Casswell et al.

    Cannabis induced impairment of performance of a divided attention task

    Nature

    (1973)
  • L.D. Chait et al.

    Effects of smoked marijuana on human performance: a critical review

  • Cited by (52)

    • Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system

      2019, Neurobiology of Stress
      Citation Excerpt :

      Additionally, electron microscopy studies have shown that CB1r are found on both glutamatergic and GABAergic presynaptic axon terminals that synapse with NE-producing LC neurons as well as post-synaptically in somatodendritic processes of LC cells (Scavone et al., 2010). The presence of CB1r on LC-NE neurons is functional, as indicated by electrophysiological studies showing that CB1r agonists and FAAH inhibitors increase the basal firing rate of LC-NE cells, c-Fos expression of LC neurons, and NE efflux in the mPFC (Gobbi et al., 2005; Oropeza et al., 2005; Mendiguren and Pineda, 2006; Muntoni et al., 2006; Page et al., 2008). The eCB system also regulates NE microcircuits in LC target regions.

    View all citing articles on Scopus
    View full text